• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


H&T Presspart Low GWP Banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Products and Services

Stevanato Group to supply syringes for Recipharm’s Resyca syringe-based SMIs

The Stevanato Group has announced that it will manufacture pre-fillable glass syringes for Recipharm's Resyca pre-filled syringe soft mist inhalers for the delivery of biologics. According to Stevanato Group, the interior of the Alba glass syringe has a silicone oil-based coating for improved particle release. The Resyca SMI is the product of a 2020 joint … [Read more...] about Stevanato Group to supply syringes for Recipharm’s Resyca syringe-based SMIs

Lonza Small Molecules adds powder characterization capabilities at Florida facility

The Lonza Small Molecules facility in Tampa, FL, USA has upgraded its powder analysis capabilities, the company said. In May 2022, Lonza announced that it was expanding its dry powder testing facilities in Tampa in order to increase its DPI development capacity. According to Lonza, the Tampa site recently added a Freeman Technologies FT4 universal powder flow … [Read more...] about Lonza Small Molecules adds powder characterization capabilities at Florida facility

Nemera and Nelson Labs announce expanded partnership

Device maker Nemera and Nelson Labs have announced the expansion of an existing partnership, with Nelson Labs performing microbiological and chemical analyses, extractables and leachables testing, and biocompatibility studies for Nemera customers.  Nemera is an associate member of the International Pharmaceutical Aerosol Consortium on Regulation & Science … [Read more...] about Nemera and Nelson Labs announce expanded partnership

Copley Scientific launches DUSA Shaker DTS 100i

Copley Scientific has announced the launch of its next generation DUSA Shaker, a semi-automated tool for rinsing dose uniformity sampling apparatus (DUSA) collection tubes. According to the company, the the new DTS 100i is a "comprehensively re-engineered and updated" version of the original DUSA Shaker that "provides full, fast, repeatable rinsing" and can be used … [Read more...] about Copley Scientific launches DUSA Shaker DTS 100i

Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products

Aptar Pharma announced that it has launched a metal-free multidose nasal spray pump called APF Futurity for delivery of over-the-counter formulations. According to Aptar Pharma, APF Futurity is designed to be recyclable without removing the pump from a container bottle and has received Class AA certification from cyclos-HT. Aptar Product Sustainability Director … [Read more...] about Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products

Berry to open new manufacturing facility in Bangalore, India

Device manufacturer Berry Global says that it intends to hire 500 employees over 8 years to staff its new manufacturing facility in Bangalore, India, which will produce a variety of products, including nasal and inhaled drug delivery devices. The company had announced plans for the site in August 2021. Berry says that the Bangalore site has received International … [Read more...] about Berry to open new manufacturing facility in Bangalore, India

Vero Biotech closes $30 million financing to support commercialization of Genosyl tankless iNO system

Vero Biotech announced an investment of $30 million from Petrichor Healthcare Capital Management that will be used for commercialization of Vero's Genosyl DS tankless inhaled nitric oxide system. The company recently announced that it had received FDA approval for the third generation Genosyl DS for delivery of iNO to increase oxygenation in newborn infants with … [Read more...] about Vero Biotech closes $30 million financing to support commercialization of Genosyl tankless iNO system

Acorda Therapeutics announces new supply agreement with Catalent for manufacture of Inbrija inhaled dry powder levodopa

Acorda Therapeutics announced that it has signed a new supply agreement with Catalent that reduces the amount of product that the company is required to buy annually from $18 million to $8.5 million for 2023 and $15.5 million for 2024. From 2025 on, the announcement says, Acorda will pay a fixed amount per capsule "based on the amount of Inbrija needed in the US and … [Read more...] about Acorda Therapeutics announces new supply agreement with Catalent for manufacture of Inbrija inhaled dry powder levodopa

Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility

Florida-based CDMO Formulated Solutions announced that it has acquired a 455,000 sq ft production facility in Cleveland, TN, USA that includes two buildings fitted with pharmaceutical production and packaging lines for a variety of dose forms such as liquids, bag-on-valve aerosols, and nasal sprays. The Tennessee facility was most recently owned by German skincare … [Read more...] about Formulated Solutions to expand its aerosol manufacturing capacity with acquisition of Tennessee facility

Third Pole gets $32 million to support development of eNOcare inhaled nitric oxide device

Inhaled nitric oxide (iNO) delivery device developer Third Pole Therapeutics announced that it has received a $32 million equity investment "from a large medical device innovator." In February 2022, the company announced the closing of a $25 million financing. Chiesi acquired global rights to develop and commercialize Third Pole's tankless iNO technology in April … [Read more...] about Third Pole gets $32 million to support development of eNOcare inhaled nitric oxide device

  • « Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Interim pages omitted …
  • Page 68
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Proveris_180x150a
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews